Stay updated on CABozantinib in NSCLC MET Clinical Trial

Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The observed updates are minor UI and content formatting changes that do not alter core study details (eligibility criteria, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-02T00:52:47.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    4%
    Check dated 2025-10-04T12:28:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Page upgraded from v3.0.2 to v3.1.0 with new contact details added; core content and key data types appear unchanged.
    Difference
    0.1%
    Check dated 2025-09-27T08:08:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed.
    Difference
    0.2%
    Check dated 2025-09-13T01:47:09.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-05T19:56:39.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has updated its facility names and locations, replacing previous terms with more specific identifiers, including the addition of 'cabozantinib' and a new version number.
    Difference
    3%
    Check dated 2025-08-29T17:00:23.000Z thumbnail image

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.